An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer

BACKGROUND: Men with metastatic castration-resistant prostate cancer (mCRPC) are living longer, therefore optimizing health-related quality of life (HRQL), as well as survival outcomes, is important for optimal patient care. The aim of this study was to assess the HRQL in patients with mCRPC receivi...

詳細記述

保存先:
書誌詳細
出版年:ESMO Open
主要な著者: Thiery-Vuillemin, A., Fizazi, K., Sartor, O., Oudard, S., Bury, D., Thangavelu, K., Ozatilgan, A., Poole, E.M., Eisenberger, M., de Bono, J.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2021
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7980065/
https://ncbi.nlm.nih.gov/pubmed/33740734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100089
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料